These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21824751)

  • 21. Aspergillus niger infection in patients with haematological diseases: a report of eight cases.
    Fianchi L; Picardi M; Cudillo L; Corvatta L; Mele L; Trapè G; Girmenia C; Pagano L
    Mycoses; 2004 Apr; 47(3-4):163-7. PubMed ID: 15078435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Echinocandin pharmacodynamics: review and clinical implications.
    Pound MW; Townsend ML; Drew RH
    J Antimicrob Chemother; 2010 Jun; 65(6):1108-18. PubMed ID: 20335190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effect of anidulafungin combined with posaconazole in experimental aspergillosis.
    Martin-Vicente A; Capilla J; Guarro J
    Med Mycol; 2017 Jun; 55(4):457-460. PubMed ID: 27760829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifungal activity of anidulafungin, a product of Aspergillus nidulans, against Aspergillus nidulans.
    Hof H; Dietz A
    Int J Antimicrob Agents; 2009 Mar; 33(3):285-6. PubMed ID: 19026523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of allicin, the reactive molecule of garlic, in inhibiting Aspergillus spp. in vitro, and in a murine model of disseminated aspergillosis.
    Shadkchan Y; Shemesh E; Mirelman D; Miron T; Rabinkov A; Wilchek M; Osherov N
    J Antimicrob Chemother; 2004 May; 53(5):832-6. PubMed ID: 15044429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of echinocandins against murine infections by Diutina (Candida) rugosa.
    Sanchis M; Sutton DA; Wiederhold NP; Guarro J; Capilla J
    Diagn Microbiol Infect Dis; 2016 Sep; 86(1):61-5. PubMed ID: 27342787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anidulafungin--state of affairs from a clinical perspective.
    Vehreschild JJ; Kümmerle T; Karthaus M; Cornely OA
    Mycoses; 2007; 50 Suppl 1():38-43. PubMed ID: 17394608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran.
    Szigeti G; Sedaghati E; Mahmoudabadi AZ; Naseri A; Kocsubé S; Vágvölgyi C; Varga J
    Mycoses; 2012 Jul; 55(4):333-8. PubMed ID: 21895787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology.
    Cafini F; Sevillano D; Alou L; Gómez-Aguado F; Corcuera MT; González N; Guinea J; Prieto J
    Rev Esp Quimioter; 2012 Mar; 25(1):47-55. PubMed ID: 22488542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a serum-based antifungal susceptibility assay to predict the in vivo efficacy of novel echinocandin compounds.
    Maki K; Matsumoto S; Watabe E; Iguchi Y; Tomishima M; Ohki H; Yamada A; Ikeda F; Tawara S; Mutoh S
    Microbiol Immunol; 2008 Aug; 52(8):383-91. PubMed ID: 18667037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The echinocandins: three useful choices or three too many?
    Bal AM
    Int J Antimicrob Agents; 2010 Jan; 35(1):13-8. PubMed ID: 19942413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary cutaneous aspergillosis due to Aspergillus niger in an immunocompetent patient.
    Mohapatra S; Xess I; Swetha JV; Tanveer N; Asati D; Ramam M; Singh MK
    Indian J Med Microbiol; 2009; 27(4):367-70. PubMed ID: 19736412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis.
    Takemoto K; Yamamoto Y; Ueda Y; Sumita Y; Yoshida K; Niki Y
    J Antimicrob Chemother; 2006 Apr; 57(4):724-31. PubMed ID: 16446374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.
    Krishnan-Natesan S; Wu W; Chandrasekar PH
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):135-7. PubMed ID: 22608136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal activity of Leptospermum petersonii oil volatiles against Aspergillus spp. in vitro and in vivo.
    Hood JR; Burton D; Wilkinson JM; Cavanagh HM
    J Antimicrob Chemother; 2010 Feb; 65(2):285-8. PubMed ID: 19952013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Echinocandin activity against Aspergillus spp. and the importance of pharmacodynamics.
    Lewis JS
    Med Mycol; 2009; 47 Suppl 1():S376-81. PubMed ID: 19296368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin.
    Ong V; Hough G; Schlosser M; Bartizal K; Balkovec JM; James KD; Krishnan BR
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6872-6879. PubMed ID: 27620474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additive action of honey and starch against Candida albicans and Aspergillus niger.
    Boukraâ L; Bouchegrane S
    Rev Iberoam Micol; 2007 Dec; 24(4):309-11. PubMed ID: 18095766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Development of a Phytopathogenic Fungi Control Trial:
    El-Baky NA; Abdel Rahman RA; Sharaf MM; Amara AAAF
    ScientificWorldJournal; 2021; 2021():6639850. PubMed ID: 33531879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.